Neogenomics Inc
F:NG9
Neogenomics Inc
F:NG9
Price:
6.984
EUR
-5.13%
Market Closed
Market Cap:
€891.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neogenomics Inc
F:NG9
|
US |
Wall St Price Targets
NG9 Price Targets Summary
Neogenomics Inc
Neogenomics Inc
Wall Street analysts forecast NG9 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for NG9 is 15.708 EUR with a low forecast of 11.364 EUR and a high forecast of 26.85 EUR.
Lowest Forecast
Price Target
11.364
EUR
63% Upside
Average Forecast
Price Target
15.708
EUR
125% Upside
Highest Forecast
Price Target
26.85
EUR
284% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NG9's stock price target?
Price Target
15.708
EUR
15.708
EUR
According to Wall Street analysts, the average 1-year price target for NG9 is 15.708 EUR with a low forecast of 11.364 EUR and a high forecast of 26.85 EUR.
What is the Revenue forecast for Neogenomics Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.
